Skip to content
★ Sign in to follow
LF

Louis Ferrari

CEO
Savient Pharmaceuticals Inc
Total declarations
16
Company
1
▲ Purchases (1 ops.)
€6,770
▼ Sales (8 ops.)
€55k

Latest filing published 23 May 2013 for SAVIENT PHARMACEUTICALS INC, €453.

Insider track record

Disclosed buys
1
Disclosed sells
8
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Louis Ferrari: trading record in brief

All filings by Louis Ferrari on record concern Savient Pharmaceuticals Inc. We count 16 filings; the first trade dates from 21 February 2011 and the latest from 22 May 2013.

The open-market side counts 1 purchase for €6,770 alongside 8 sales for €55k. Netting one side against the other leaves €49k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants. Since January 2013: no purchases and 4 sales on the market.

The record was last updated on 23 May 2013 with an open-market sale (€453) in Savient Pharmaceuticals Inc. The last purchase on record was published on 22 November 2011, which is 5,466 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Louis Ferrari

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations